logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Incyte Corporation Skyrockets on Promising Trial for Jakafi

  +Follow August 21, 2013 9:20AM
Share:
Tickers Mentioned:

Pharmaceutical company Incyte Corporation (INCY) released very positive news on Aug. 21, revealing that their pancreatic cancer treatment drug ruxolitinib, marketed under the trade name Jakafi, had performed very well in Phase II trials, and that the drug could now move on to Phase III.

Incyte Executive Vice President Richard S. Levy pointed out that sufferers from advanced pancreatic cancer currently have very few options. If approved, the orally-administered drug would be one of the first on the market that exists as "an attractive treatment option" for sufferers of pancreatic cancer.

If approved by the FDA, this would be a major breakthrough. Metastatic pancreatic cancer has the lowest survival rate of any form of cancer. Currently, less than one percent of people afflicted survive more than five years.

Jakafi's ability to increase lifespan for sufferers looks very promising. In the Phase II trials, the six month survival rate for patients (when coupled with chemotherapy treatment) for Jakafi was 42 percent, compared to 11 percent for patients on a placebo.

Jakafi was first approved by the Food and Drug Administration in 2011 to treat a bone marrow disease. After its success in that arena, the company specualted that the drug might effectively treat other types of cancer as well. Now, the drug is fast aproaching approval to treat pancreatic cancer as well. Though it is currently the only drug the company has gotten passed by the USFDA. Jakafi seems to be fulfilling early analyst speculation that it could be a billion dollar blockbuster drug for the Delaware-based drug maker.

Incyte earned $54.1 million from sales of Jakafi in the second quarter of 2013, and expects to earn between $220 and $230 million total this year.

Incyte rocketed on the news, and went up 29.19 percent to hit $34.88 a share. They’re up 58.82 percent on the year.

(image courtesy of Wikimedia commons)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Signup for our daily newsletter and get our best articles emailed right to you!

Results for INCY
danrocks
1 Sep 15 09:00:31
Right now INCY is number 122 for the largest percentage gain out of 250 stocks. $INCY INCY is up +11.59% in th http://t.co/ADxbJmm8sy
Robert Durant
1 Sep 15 08:44:52
I think $INCY gets bought out this year, great pipeline
Kristina Duering
1 Sep 15 08:40:08
$INCY like a ROCK, it rocks higher in this crazy market! WOW! Happy long :)
DailyStockPicks
1 Sep 15 07:34:19
$ANFI huge bounce play like $ACI. 100%+ upside potential P/E of 3 $CERN $NU $INCY $RWLK $JWA $ARLP investors read http://t.co/L1jwUV6Bag
david maret
1 Sep 15 07:09:06
RT @HumbleBioTrader: Going into the fall, my favorite 3 biotech stocks: $INCY, $BLUE, $VRTX
CC
1 Sep 15 06:56:11
$INCY just went green, Bios rebounding today
HumbleBioTrader
1 Sep 15 06:50:14
RT @AnalystWire: IDO Trial Upsizing Seen as Positive Indicator for Incyte $INCY, UBS Says http://t.co/akdDFL3ELn
SIAnalystWire
1 Sep 15 06:49:58
IDO Trial Upsizing Seen as Positive Indicator for Incyte $INCY, UBS Says http://t.co/akdDFL3ELn
HumbleBioTrader
1 Sep 15 06:49:58
$INCY green beast!!!
Trackur
1 Sep 15 06:48:15
$INCY missed the bus :(
Trackur
1 Sep 15 06:33:24
$INCY holding up so far this morning, might look for a long call entry when things settle out.
ProTradersNews
1 Sep 15 05:51:03
$ACHN $INCY $XOMA: Three Biotech Stocks Are Tumbling: Achillion Pharmaceuticals, Inc …: http://t.co/Z1qdoHU7BM
biotech 2050
1 Sep 15 05:26:50
10 #biotech co. have $53B in #cash $GILD $AMGN $CELG $BIIB $REGN $REGN $ALXN $VRTX $BMRN $INCY Add cash owned by $PFE $NVS $RHHBY #buyouts?
$Stocknewsalerts
1 Sep 15 05:02:42
$INCY Incyte to Present at Upcoming Investor Conferences From our Stock News Alerts App
Ken Shreve
1 Sep 15 03:01:24
3 Under-The-Radar Biotech Stocks With Bullish Charts http://t.co/oUFVz8rik2 $AMAG $INCY $ANAC
BreakingStocksNews
1 Sep 15 02:32:03
$INCY: Incyte Corporation Analyst Rating Update: http://t.co/b7wulRRjnD
jjz
31 Aug 15 23:52:51
RT @Ogut_Ozgur: $INCY / $BMY nivo + incb24360 trial NCT02327078 recently added an explicit P2 glioblastoma cohort. Indication was not inclu…
Sleek Money
31 Aug 15 23:06:20
Incyte Hits New 52-Week High at $121.93 $INCY http://t.co/Fq8zZPWFRI
Clark Joseph Kent
31 Aug 15 20:49:17
#IBD Estimate Beaters $LGND $ACIW $POST $AMZN $AGO $ADPT $ABMD $INCY $SKYW $CINF http://t.co/H3miVL0yoa
jjz
31 Aug 15 18:48:48
RT @dougheuringaria: Summary list of checkpoints that allow co-stimulation or co-inhibition of T cells $INCY $AFMD $AGEN $TSRO http://t.co/…
jjz
31 Aug 15 18:48:44
RT @dougheuringaria: Summary of key ongoing combination clinical studies PD-1/ L1 drugs with other immuno-oncology $MRK $BMY $AZN $INCY ht…
Robert Lesnicki
31 Aug 15 16:54:23
52 week high list for 8/31: http://t.co/a18g4nI4OT $INCY $COMM $POST $MDCO $SWHC
TheBurdetteLawFirm
31 Aug 15 16:35:05
Today's 52wk highs by volume: $MDCO $HRTX $INCY $SWHC $COMM $SRPT $POST $EFOI $SIG $CRWN $BRSS $DXLG $AXGN $SPWH $LJPC $VRTU $TANH $NDRM
GTLackeyJr CMT
31 Aug 15 16:32:09
August 31, 2015 RS Movers http://t.co/4U4UPOUoYA $QQQ $DTN $FDN $XLY $GDX $ROOF $INCY $BMRN $KBH $CLB $OXY $DIS $SWC $AEM
SwingTradeBot
31 Aug 15 15:01:57
Scan results - New 52 Week High today: $MDCO $HRTX $EFOI $SWHC $INCY $COMM $POST $SRPT $SIG $NDRM ... http://t.co/jVoayFlTYm
Hazel Dutton
31 Aug 15 14:36:19
RT @Ogut_Ozgur: $INCY / $BMY nivo + incb24360 trial NCT02327078 recently added an explicit P2 glioblastoma cohort. Indication was not inclu…
HumbleBioTrader
31 Aug 15 12:42:35
Going into the fall, my favorite 3 biotech stocks: $INCY, $BLUE, $VRTX
Jaclyn Fanger
31 Aug 15 12:18:03
RT @Ogut_Ozgur: Also a big expansion of $INCY $MRK trial NCT02178722 of MK-3475 + INCB24360. More specific tumour types, enrollment target …
Miljenko Zuanic
31 Aug 15 11:05:36
@Ogut_Ozgur Finally they figure out that they do not need "double blind" in cancer trial! $INCY :-)
Jason Chew
31 Aug 15 11:03:43
RT @Ogut_Ozgur: Also a big expansion of $INCY $MRK trial NCT02178722 of MK-3475 + INCB24360. More specific tumour types, enrollment target …
Jason Chew
31 Aug 15 11:03:38
RT @Ogut_Ozgur: $INCY / $BMY nivo + incb24360 trial NCT02327078 recently added an explicit P2 glioblastoma cohort. Indication was not inclu…
David Sobek
31 Aug 15 10:39:15
RT @Ogut_Ozgur: Also a big expansion of $INCY $MRK trial NCT02178722 of MK-3475 + INCB24360. More specific tumour types, enrollment target …
HumbleBioTrader
31 Aug 15 10:27:54
RT @Ogut_Ozgur: Also a big expansion of $INCY $MRK trial NCT02178722 of MK-3475 + INCB24360. More specific tumour types, enrollment target …
HumbleBioTrader
31 Aug 15 10:27:38
RT @Ogut_Ozgur: $INCY / $BMY nivo + incb24360 trial NCT02327078 recently added an explicit P2 glioblastoma cohort. Indication was not inclu…
Ozgur Ogut
31 Aug 15 10:27:25
Also a big expansion of $INCY $MRK trial NCT02178722 of MK-3475 + INCB24360. More specific tumour types, enrollment target almost tripled
BATTLE THE BTK
31 Aug 15 10:25:37
RT @Ogut_Ozgur: $INCY / $BMY nivo + incb24360 trial NCT02327078 recently added an explicit P2 glioblastoma cohort. Indication was not inclu…
Ozgur Ogut
31 Aug 15 10:23:27
$INCY / $BMY nivo + incb24360 trial NCT02327078 recently added an explicit P2 glioblastoma cohort. Indication was not included in P1.
ProVesting
31 Aug 15 10:09:02
$BMY $INCY: Bristol-Myers Squibb Co (NYSE: BMY) Gets Rights to Acquire …: http://t.co/9VHiU1o4Kn
Stan
31 Aug 15 10:06:47
RT @dougheuringaria: Summary of key ongoing combination clinical studies PD-1/ L1 drugs with other immuno-oncology $MRK $BMY $AZN $INCY ht…
Stan
31 Aug 15 10:06:43
RT @dougheuringaria: Summary list of checkpoints that allow co-stimulation or co-inhibition of T cells $INCY $AFMD $AGEN $TSRO http://t.co/…
David Busick
31 Aug 15 08:17:44
RT @MitchellKWarren: Unusual Options Activity: MCD, FAST, OIH, HOT, And More http://t.co/c017O7SKpE via @seeitmarket $INCY $TTPH $LL $MCD $…
See It Market
31 Aug 15 08:17:38
RT @MitchellKWarren: Unusual Options Activity: MCD, FAST, OIH, HOT, And More http://t.co/c017O7SKpE via @seeitmarket $INCY $TTPH $LL $MCD $…
PTSD_Trader
31 Aug 15 07:50:45
$INCY Big time strength on this one.
Quantcha
31 Aug 15 07:19:18
52-Week High Alert: Trading today’s movement in INCYTE $INCY http://t.co/oONcXq4nJg
Mitchell Warren
31 Aug 15 07:09:07
Unusual Options Activity: MCD, FAST, OIH, HOT, And More http://t.co/c017O7SKpE via @seeitmarket $INCY $TTPH $LL $MCD $OIH
PolgarStocks
31 Aug 15 06:46:07
SLV iShares Silver Trust Stock Forum http://t.co/Bbjl92Atns $SLV $INCY $VG $RYAM #SLV #share #stock
Investors Hangout
31 Aug 15 06:45:36
SH ProShares Short S&P 500 Fund Financials http://t.co/MfpTpxN7Np $SH $FHC.TO $INCY $FHC.TO #SH #stockmarket #stockmarket
leahanne
31 Aug 15 06:44:19
PCLN http://t.co/yzDlvAT8FF Inc. Ask http://t.co/v28bKPCZsn $PCLN $ONOV $CRGP $INCY #PCLN #stock #tradeideas
Emylers
31 Aug 15 06:44:11
QCOM QUALCOMM Inc. Yield http://t.co/UK7QtIiv3L $QCOM $INCY $HLF $VXX #QCOM #tradeideas #finance
Stock Forums
31 Aug 15 06:43:11
PHM.V Patient Home Monitoring Corp. Bid Size http://t.co/CNuHCnGAi0 $PHM.V $INCY $COST $CVC #PHM.V #stockmarket #nasdaq
				
				
  +Follow August 21, 2013 9:20AM
Share:

Comments

 

blog comments powered by Disqus

 Today's Must Reads

Welcome to Equities.com's Small-Cap Throwdown


These Analysts Called Apple's (AAPL) Collapse, Here's What They're Saying Now

7 Dow Stocks Worth Owning and a Lot that Aren't

Sprint Turnaround Has Begun


Saving the

Small-Cap Market

 

Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN